Señales en vivo de MRKR | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 14:36):
Our systems believe the stock currently is overvalued by -0.09% compare to its pairs and should correct downwards.

Stats
Volumen de hoy	16 302
Volumen promedio	20 016
Capitalización de mercado	41.47M
EPS	$-0.270 ( Q1 \| 2024-05-15 )
Próxima fecha de ganancias	( $-0.430 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.37 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0390 (0.84%)

AADI -8.24%

ABCL 1.28%

ABCM 0.04%

ABEO -3.32%

ABIO -1.68%

ABOS 3.73%

ABSI 3.91%

ABUS -0.82%

ABVX -3.00%

ACAD -0.45%

ACER -17.95%

ACET -9.15%

ACGN 1.29%

ACHL -2.48%

ACHV 3.66%

ACIU -1.50%

ACLX -0.44%

ACRV -5.28%

ACST -1.63%

ACXP 3.92%

ADAG 6.07%

ADAP -3.42%

ADGI 0.87%

ADIL -1.75%

ADMA -1.95%

ADPT 1.02%

ADTX -2.78%

ADVM 1.01%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -2.97%

AGEN -3.90%

AGIO -2.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 4.30%

AKRO -2.55%

AKTX 0.35%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC -0.11%

ALGS -1.52%

ALKS 1.61%

ALLK -11.39%

ALLO -3.96%

ALLR -0.34%

ALNA 3.16%

ALNY 2.11%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -14.23%

ALVR -0.76%

ALXN 0.00%

ALXO -14.22%

ALZN 4.02%

AMRN -2.48%

AMTI -3.13%

ANAB 1.01%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 2.07%

ANPC -3.15%

APGE 1.01%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.79%

APLT -1.13%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.47%

ARDS -12.13%

ARDX 0.50%

ARGX -0.59%

ARNA 0.00%

ARPO -0.90%

ARQT -2.97%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.42%

ARWR -1.86%

ASLN -3.44%

ASMB -4.22%

ASND -2.18%

ATAI -5.17%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.85%

ATRA -3.60%

ATXI -2.78%

ATXS -0.94%

AUPH -1.17%

AURA 4.26%

AUTL -3.30%

AVBP -5.03%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE -1.03%

AVTX -3.74%

AVXL -5.43%

AXLA 0.00%

AXSM -1.39%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.54%

BCAB -5.56%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.81%

BCTX 10.20%

BCTXW 13.02%

BCYC 1.00%

BDRX -4.01%

BDTX -0.64%

BEAM 2.19%

BFRA -2.91%

BGNE -2.25%

BIOR -4.69%

BIVI 2.79%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.18%

BLTE -1.13%

BLU 0.03%

BLUE -2.28%

BMEA -14.20%

BMRN 0.51%

BNOX 6.15%

BNTC -3.06%

BNTX -1.75%

BOLD -9.03%

BOLT -0.05%

BPMC -1.64%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -4.29%

BTAI 12.29%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.35%

CABA 1.66%

CADL 0.53%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -0.43%

CARA -3.23%

CARM 7.39%

CASI 3.86%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.87%

CCXI 0.00%

CDAK 0.00%

CDIO -2.99%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT -1.68%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.58%

CDXS 8.28%

CELC -3.49%

CELU 1.33%

CELUW 11.80%

CERC -1.68%

CERE -1.62%

CERO -6.70%

CEROW -10.18%

CFRX -27.95%

CGEM -0.37%

CGEN -3.31%

CGON -1.45%

CGTX -3.98%

CHMA -6.00%

CHRS 3.81%

CINC 0.00%

CING 2.22%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -1.19%

CLGN 0.00%

CLLS -3.11%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.04%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 4.84%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 0.67%

CNTB -0.75%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -2.28%

CORT 2.34%

COYA -0.33%

CPRX -1.91%

CRBP -0.83%

CRBU -7.10%

CRDF 0.66%

CRGX -0.74%

CRIS -1.59%

CRNX -6.35%

CRSP 0.02%

CRTX 2.63%

CRVO -3.95%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.34%

CUE -3.11%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.94%

CYTO 0.00%

DARE 2.94%

DAWN -0.90%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.07%

DNLI -2.17%

DNTH -6.46%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.72%

DTIL 0.63%

DYAI 9.68%

EARS -1.77%

EDIT -3.02%

EDSA 4.09%

EFTR 2.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.40%

ELEV -1.87%

ELOX 10.77%

ELTX -5.15%

ELVN -1.40%

ELYM 5.09%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.73%

ENTO -4.97%

ENTX -1.34%

ENVB 4.72%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 1.68%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.58%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.02%

EVLO 0.00%

EWTX -0.81%

EXAI -0.94%

EXEL 0.49%

EYEG -0.69%

EYEN 0.00%

EYPT 0.97%

FATE -11.96%

FBIO 0.59%

FBIOP 0.87%

FBLG -4.80%

FBRX -0.02%

FDMT -5.68%

FENC -2.52%

FGEN -9.87%

FHTX 6.96%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.57%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.49%

FULC 1.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -3.08%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -2.43%

GHRS -3.72%

GLMD -4.09%

GLPG -1.71%

GLSI 5.01%

GLTO -3.31%

GLUE -3.69%

GLYC -12.38%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.65%

GNPX -3.43%

GNTA 3.94%

GOSS -9.45%

GOVX -1.36%

GOVXW 10.89%

GPCR -6.99%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.44%

GRTX -1.66%

GTHX 1.82%

GUTS 0.35%

GXGXW 41.67%

GYRE -4.99%

HALO -1.62%

HARP 0.09%

HCWB -6.13%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -1.30%

HOOK 1.97%

HOTH -1.65%

HOWL 0.85%

HRMY 3.59%

HRTX 8.36%

HSTO 0.00%

HUMA 1.12%

HUMAW -6.26%

IBRX -6.32%

ICCC -3.10%

ICPT 0.21%

ICU 16.82%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.29%

IFRX -2.78%

IGMS -1.39%

IKNA -0.89%

IKT -9.93%

IMAB 0.00%

IMCR -3.41%

IMGN 0.02%

IMGO 0.00%

IMMP 5.13%

IMMX -6.90%

IMNM 3.73%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.38%

IMTXW 6.00%

IMUX 2.31%

IMV 0.00%

IMVT -3.52%

INAB -0.72%

INBX -2.65%

INCY -2.23%

INDP 7.34%

INFI -52.38%

INKT 1.69%

INM 0.04%

INMB 4.62%

INO 2.86%

INSM -1.05%

INTS -1.96%

INVA 0.28%

INZY 1.72%

IOBT -10.24%

IONS 1.21%

IOVA -2.72%

IPA 3.00%

IPHA 5.08%

IPSC -2.73%

IRON -2.67%

ISEE 0.38%

ITOS 1.68%

ITRM 2.33%

IVA 6.96%

IVVD -0.41%

JAGX 1.05%

JANX -4.70%

JAZZ -1.01%

JNCE 0.00%

JSPR -2.49%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.16%

KDNY 0.22%

KMPH -0.34%

KNSA -2.03%

KNTE -0.38%

KOD -7.71%

KPRX -4.08%

KPTI -8.49%

KRBP -10.00%

KRON 1.58%

KROS -0.53%

KRRO -2.42%

KRTX 0.03%

KRYS 0.19%

KTRA 14.31%

KTTA -0.65%

KTTAW 0.92%

KURA 0.68%

KYMR -3.37%

KYTX -4.13%

KZIA 2.40%

KZR -0.21%

LABP 0.57%

LBPH -0.32%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.79%

LENZ -2.77%

LEXX -1.54%

LEXXW -14.63%

LGND -1.18%

LGNDV 0.00%

LGVN -10.14%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA -0.16%

LRMR -0.07%

LSTA -1.68%

LTRN 5.74%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -1.76%

LYEL -35.05%

LYRA 3.99%

MACK 0.10%

MBIO -11.22%

MBRX -1.43%

MCRB 2.95%

MDGL -2.24%

MDNA -13.16%

MDWD 3.46%

MDXG -1.69%

MEIP 0.00%

MESO -1.71%

MGNX -5.36%

MGTA -7.74%

MGTX -0.71%

MGX 2.14%

MIRM 0.36%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX -0.03%

MLYS -6.49%

MNKD -0.86%

MNMD 2.97%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.42%

MORF -3.15%

MREO 0.00%

MRKR -0.43%

MRNA -9.10%

MRNS -6.59%

MRSN -2.86%

MRTX -0.17%

MRUS -0.19%

MRVI 0.07%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.00%

NAMSW -0.21%

NAUT 0.89%

NBRV 0.71%

NBSE -1.56%

NBTX 8.40%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.31%

NKGN 9.85%

NKGNW -18.03%

NKTR 3.74%

NKTX -3.43%

NLSP 3.53%

NLSPW 26.67%

NMRA -2.00%

NMTR -42.97%

NOVN -24.84%

NRBO 14.44%

NRIX -0.79%

NRSN -4.82%

NRSNW 0.00%

NRXP -7.43%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.62%

NTEC -12.45%

NTHI 0.00%

NTLA -5.54%

NTRBW -31.07%

NUVL -1.27%

NVAX -6.82%

NVCT -7.46%

NVIV -34.28%

NXTC -5.29%

NYMX -0.05%

OABI 2.64%

OABIW -10.06%

OBIO 1.90%

OBSV 0.00%

OCEA -2.82%

OCGN 8.02%

OCS -1.00%

OCUL 0.61%

OCUP 1.31%

ODT -4.27%

OKYO 1.72%

OLMA -5.37%

OMER -2.57%

OMGA -0.42%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -4.00%

ORGS -0.69%

ORIC -3.56%

ORMP 18.08%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.25%

OVID 0.30%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.87%

PCSA -1.93%

PCVX -0.09%

PDSB -6.80%

PEPG 1.37%

PGEN -7.19%

PHAR 2.19%

PHAS 0.00%

PHAT -0.87%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.38%

PLUR 7.39%

PMN -5.55%

PMVP -3.27%

PNT 0.16%

PPBT -6.87%

PRAX 6.98%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK -0.67%

PRQR 1.21%

PRTA -2.99%

PRTC 0.62%

PRTG 0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.97%

PSTX -3.29%

PTCT -0.68%

PTE -0.82%

PTGX -1.07%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 3.76%

QLGN -2.78%

QNCX 5.70%

QNRX -0.08%

QSI -32.70%

QSIAW -20.47%

QTTB 1.83%

QURE -1.08%

RAIN -1.63%

RANI 4.81%

RAPT -2.27%

RARE 2.06%

RCKT -10.02%

REGN -0.39%

RENB -3.73%

REPL -2.38%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -6.06%

RGNX -6.66%

RIGL -6.24%

RLAY -4.90%

RLMD 0.00%

RLYB -4.36%

RNA 1.84%

RNAC -4.53%

RNAZ -0.96%

RNXT 1.79%

ROIV -1.94%

ROIVW 4.56%

RPHM -1.86%

RPRX -0.72%

RPTX -0.88%

RUBY 2.70%

RVLP -32.05%

RVMD -0.86%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.40%

RYTM -6.28%

RYZB 0.02%

RZLT 2.07%

SABS -1.37%

SABSW -11.81%

SAGE 0.00%

SANA -2.86%

SAVA -2.10%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 9.85%

SCPS 0.00%

SEEL -4.87%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.39%

SGMT -5.33%

SGTX -2.56%

SIOX 22.63%

SLDB -2.76%

SLGL 5.23%

SLN -7.52%

SLNO 0.62%

SLRX -0.81%

SLS -2.56%

SMMT -3.37%

SNDX 2.97%

SNGX 2.08%

SNPX 0.23%

SONN -2.15%

SPPI -0.49%

SPRB -1.36%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.21%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -7.20%

STRO -2.51%

STSA 0.00%

STTK 6.47%

SURF -0.93%

SVRA -2.75%

SWTX -0.44%

SYBX 1.29%

SYRS -2.24%

TALS -0.73%

TARA -7.38%

TARS -2.13%

TBPH 0.71%

TCBP 9.58%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -1.75%

TCRX 3.39%

TECH -0.83%

TENX -0.32%

TERN -8.28%

TFFP -7.61%

TGTX -7.35%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -6.26%

TNGX -3.35%

TNXP -6.40%

TNYA -4.38%

TPST 5.34%

TRDA -4.77%

TRVI 2.68%

TRVN 0.68%

TSHA -19.07%

TSVT -4.12%

TTNP -6.05%

TVTX 3.20%

TYRA -6.83%

UBX -2.13%

UNCY -4.00%

URGN 2.49%

UTHR -0.11%

VACC 11.36%

VALN -6.70%

VAXX 106.25%

VBIV 0.91%

VBLT -8.77%

VCEL 0.98%

VCNX 8.60%

VCYT -1.01%

VERA -5.26%

VERU 2.69%

VERV -2.87%

VIGL -1.08%

VINC 2.93%

VIR -1.08%

VIRI -5.66%

VIRX 3.98%

VKTX -1.62%

VLON -13.04%

VNDA -3.99%

VOR -6.05%

VRCA 0.50%

VRDN -4.15%

VRNA -1.93%

VRPX 1.02%

VRTX 0.08%

VSTM 4.12%

VTGN -1.20%

VTVT 0.39%

VTYX -3.14%

VXRT -1.85%

VYGR -0.83%

VYNE -6.29%

VYNT 7.78%

WINT -2.72%

WVE -8.91%

XBIO 1.03%

XBIT 6.72%

XCUR 3.13%

XENE -1.77%

XERS 4.52%

XFOR 4.69%

XLO 4.42%

XLRN 0.00%

XNCR 0.26%

XOMA -8.79%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.73%

ZNTL -1.79%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-06-30	Lurier Eliot M	Buy	0
2021-03-16	Eansor Norman David	Buy	14 285	Common Stock
2023-06-06	Eansor Norman David	Buy	8 000	Stock Option (right to buy)
2021-03-25	Eansor Norman David	Buy	7 142	Common Stock
2021-03-25	Eansor Norman David	Sell	14 285	Common Stock

INSIDER POWER
100.00
Last 91 transactions
Buy: 66 397 235 \| Sell: 1 245 536

Correlación (AI algo v.1.1b): Overvalued: -0.09% $4.65 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Marker Therapeutics Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Marker Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$3.31M
Beneficio Bruto:	$-7.11M (-214.60 %)
EPS:	$-1.930

FY	2023
Ingresos:	$3.31M
Beneficio Bruto:	$-7.11M (-214.60 %)
EPS:	$-1.930

FY	2022
Ingresos:	$9.00M
Beneficio Bruto:	$5.32M (59.13 %)
EPS:	$-3.58

FY	2021
Ingresos:	$1 242.00
Beneficio Bruto:	$1 241.71 (100.00 %)
EPS:	$-8.90

Financial Reports:

No articles found.

Marker Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Marker Therapeutics Inc

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.